Oruka Therapeutics, Inc. (ORKA) › Net IncomeOruka Therapeutics, Inc. (ORKA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2004: -$511.0K2005: -$1.46M2006: -$5.24M2007: -$13.99M2008: -$19.43M2009: -$9.14M2010: -$8.42M2011: -$5.36M2012: -$4.32M2013: -$6.94M2014: -$9.69M2015: -$11.45M2016: -$16.44M2017: -$18.49M2018: -$7.93M2019: -$5.48M2020: -$9.74M2021: -$19.32M2022: -$9.93M2023: -$5.34M2025: -$105.43M-$105.43M2004Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$105.43M—2023-$5.34M+46.2%2022-$9.93M+48.6%2021-$19.32M-98.4%2020-$9.74M-77.6%2019-$5.48M+30.9%2018-$7.93M+57.1%2017-$18.49M-12.4%2016-$16.44M-43.7%2015-$11.45M-18.1%2014-$9.69M-39.6%2013-$6.94M-60.6%2012-$4.32M+19.5%2011-$5.36M+36.3%2010-$8.42M+7.9%2009-$9.14M+53.0%2008-$19.43M-38.9%2007-$13.99M-167.0%2006-$5.24M-259.2%2005-$1.46M-185.5%2004-$511.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share